15 Sep 2020

Ansa raises funds for DNA synthesis technology development

Ansa Biotechnologies has raised $7.9m as part of its oversubscribed seed financing round. Horizons Ventures led the financing round, with participation from Humboldt Fund, Mubadala Capital and other investors. The…

15 Sep 2020

Merck to acquire $1bn equity stake in Seattle Genetics

Drugmaker Merck is acquiring a $1bn equity stake in Seattle Genetics as part of oncology collaborations with the company. The companies will develop and market Seattle Genetics’ ladiratuzumab vedotin, an…